Press Releases
Citius Pharma Announces Addition of South America to World License
Citius Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced that it has recently concluded...
Press Releases
Aptar Pharma Preservative-Free Multidose Dispenser Chosen For The First Time For A Prescription Dry Eye Product In The Us With Restasis Multidose
Aptar Pharma’s innovative and patented preservative-free multidose Ophthalmic Squeeze Dispenser is available for patients in the U.S. prescription market for the first time with Allergan’s...
White Papers
Selecting a dosage form for drug delivery to the lungs
Recipharm is frequently asked to help its clients select and develop an appropriate dosage form for their inhalation product development programs.When choosing between metered dose inhaler...
Press Releases
Recipharm partners with Sato to manufacture product for Japanese market
Recipharm, the contract development and manufacturing organisation (CDMO), has entered into a long term agreement with Sato Pharmaceutical Co. for the commercial manufacture and...
Press Releases
X-Chem Announces Strategic Collaboration with Astellas Pharma Across Multiple Therapeutic Areas
X-Chem, Inc. , a privately held biotechnology company applying its innovative drug discovery capabilities to the generation of novel small molecule therapeutics, announced the...
Press Releases
Lilly’s Taltz Receives U.S. FDA Approval For The Treatment Of Moderate-To-Severe Plaque Psoriasis
Eli Lilly and Company announced today that the U.S. FDA has approved Taltz® injection 80 mg/mL for the treatment of moderate-to-severe plaque psoriasis in...
Clinical Trials
Selvita Announces First Patient Dosed in Phase I/II Clinical Trial of SEL24 in Acute Myeloid Leukemia
Selvita , a clinical stage drug discovery and development company focused on innovative medicines for patients with blood cancers, announced that the first patient...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read